Merus Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Merus's estimated annual revenue is currently $2.1M per year.(i)
  • Merus's estimated revenue per employee is $101,500

Employee Data

  • Merus has 21 Employees.(i)

Merus's People

NameTitleEmail/Phone
1
Manager Customer SupportReveal Email/Phone
2
Customer Success ManagerReveal Email/Phone
3
Customer Success SpecialistReveal Email/Phone
4
Data Migration CoordinatorReveal Email/Phone
5
Product OwnerReveal Email/Phone
6
Implementation & Customer Success SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.3M37N/AN/AN/A
#2
$82.1M453N/AN/AN/A
#3
$154.1M7863%N/AN/A
#4
$3.8M34N/AN/AN/A
#5
$5.2M45N/AN/AN/A
#6
$0.9M10N/AN/AN/A
#7
$4.6M40N/AN/AN/A
#8
$4M36-10%$350K.N/A
#9
$42.4M266N/AN/AN/A
#10
$18.1M125N/AN/AN/A
#11
$30.6M1962%N/AN/A
#12
$1.6M18N/AN/AN/A
#13
$4.7M25N/AN/AN/A
#14
$9.5M73N/AN/AN/A
#15
$2.4M24N/AN/AN/A
#16
$1M12N/AN/AN/A
#17
$0.2M3N/AN/AN/A
#18
$0.1M80%$73.3MN/A
#19
$22.3M14519%N/AN/A
#20
$0.4M6N/AN/AN/A
Add Company

What Is Merus?

keywords:N/A

N/A

Total Funding

21

Number of Employees

$2.1M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Merus News

2022-04-13 - $8.55 Million in Sales Expected for Merus (NASDAQ:MRUS ...

Get Merus alerts: Several equities research analysts have issued reports on the stock. Needham & Company LLC assumed coverage on shares of...

2022-04-06 - Should You Buy Merus NV (MRUS) in Biotechnology Industry?

MRUS received an overall rating of 62, which means that it scores higher than 62 percent of all stocks. Merus NV also achieved a score of 87 in...

2022-04-06 - Merus Presents Preclinical Data on MCLA-129 at the ...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 08, 2022 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”, or “...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.6M21-16%N/A
#2
$3.3M215%N/A
#3
$2.4M21-9%N/A
#4
$2.1M2124%N/A
#5
$1.5M21-5%N/A